Straits Times Index
3,313.48 +8.49 (+0.26%) Nikkei
38,787.38 -132.88 (-0.34%) Hang Seng
19,553.61 +177.08 (+0.91%) FTSE 100
8,420.26 -18.39 (-0.22%) Bitcoin USD
66,812.56 +1,453.59 (+2.22%) CMC Crypto 200
1,350.62 -23.22 (-1.69%)
AVIR May 2024 2.500 call
| Previous close | 1.1800 |
| Open | 1.1800 |
| Bid | 0.0000 |
| Ask | 2.1000 |
| Strike | 2.50 |
| Expiry date | 2024-05-17 |
| Day's range | 1.1800 - 1.1800 |
| Contract range | N/A |
| Volume | |
| Open interest | 1 |
- GuruFocus.com
Atea Pharmaceuticals Inc (AVIR) Q1 2024 Earnings Call Transcript Highlights: Strategic Progress ...
Discover key updates on Atea's financial health, clinical advancements, and strategic outlook as they pave the way through 2024.
GlobeNewswireAtea Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
Full Enrollment Achieved in Global Phase 3 SUNRISE-3 Trial for Treatment of COVID-19 with Results Expected 2H’24 Global Phase 2 HCV Study On Track to Report Complete SVR12 Results 2H’24 Multiple Presentations Showcasing Preclinical and New Phase 2 Efficacy Data to be Presented at European Association for the Study of the Liver (EASL) Congress 2024 Conference Call at 4:30 pm ET Today BOSTON, May 14, 2024 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-s
- GlobeNewswire
Atea Pharmaceuticals to Host First Quarter 2024 Financial Results Conference Call on May 14, 2024
BOSTON, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced that it will host a live conference call and audio webcast on Tuesday, May 14, 2024, at 4:30 p.m. ET to report financial results for the first quarter ended March 31, 2024, and to provide a business update. To access the live conference call
